Immunovant, Inc. - COM (IMVT)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
78.6M
Holdings value Q3 2024
$2.24B
Value change Q3 2024
+$115M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
180
Number of buys Q3 2024
88
Number of sells Q3 2024
-97
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 78.6M $2.24B +$115M $28.51 184
2024 Q2 74.7M $1.97B +$112M $26.40 196
2024 Q1 69.6M $2.25B +$6.66M $32.31 211
2023 Q4 68.1M $2.87B +$20.7M $42.13 228
2023 Q3 68.1M $2.62B +$462M $38.39 187
2023 Q2 55.5M $1.05B -$33.1M $18.97 149
2023 Q1 58.3M $904M +$20.9M $15.51 141
2022 Q4 56.5M $1B +$261M $17.75 132
2022 Q3 42.7M $238M +$13.9M $5.58 107
2022 Q2 40.1M $156M +$2.27M $3.90 88
2022 Q1 39.5M $218M -$1.33M $5.51 109
2021 Q4 37.8M $322M -$6.09M $8.52 119
2021 Q3 33.8M $293M -$50M $8.69 119
2021 Q2 38.6M $408M -$67.7M $10.57 116
2021 Q1 40.3M $646M -$273M $16.04 122
2020 Q4 40.3M $1.86B +$41.3M $46.19 146
2020 Q3 39.8M $1.4B +$384M $35.19 116
2020 Q2 28.6M $696M +$388M $24.35 87
2020 Q1 12.6M $194M +$20M $15.56 40
2019 Q4 11.3M $176M +$163M $15.87 24